Insiders at a number of U.S.-listed companies reported material trades in recent filings with the Securities and Exchange Commission, with purchases and sales disclosed for transactions executed on July 30 and 31, 2026, and on August 3, 2026. The following is a company-by-company account of the most significant transactions reported for the trading days in question, including purchase and sale amounts, per-share prices, and changes in beneficial ownership as recorded in the corresponding Form 4 filings.
Top buys
Hanover Bancorp, Inc. (NASDAQ: HNVR) - President Kevin M. O’Connor reported a direct purchase of 10,000 shares of common stock on July 30, 2026. The acquisition was made at $26.88 per share for a total cash outlay of $268,800. Following this direct purchase, the filing shows Mr. O’Connor beneficially owns 12,300 shares of Hanover Bancorp common stock. The transaction occurred while the company’s share price was trading near its 52-week high of $27.08 and after a year-to-date price rise that produced a 27% total return over the past year. InvestingPro commentary cited in the filing indicates the stock appears slightly overvalued relative to InvestingPro’s Fair Value estimate.
Protagenic Therapeutics, Inc. (NASDAQ: PTIX) - Executive Chair and Principal Officer Garo H. Armen disclosed an acquisition of 26,291 shares of common stock on July 30, 2026. The shares were purchased at $0.1828 apiece, for a total purchase price of $4,805. After the transaction, Mr. Armen’s direct beneficial ownership of Protagenic Therapeutics common stock stood at 26,291 shares. The filing notes that the stock is trading near a 52-week low of $0.13 and has fallen sharply from a 52-week high of $6.20. Additional commentary included in the disclosure states that over the last week the stock declined over 16% and that InvestingPro analysis assesses the stock as currently overvalued relative to its Fair Value estimate.
Anixa Biosciences Inc. (NASDAQ: ANIX) - Chief Executive Officer and Director Amit Kumar acquired 5,000 shares of common stock on July 31, 2026, according to the Form 4 filing. The shares were purchased at $3.47 each for a total of $17,350. Following the purchase, Mr. Kumar directly holds 657,000 shares of Anixa Biosciences common stock. The filing situates the buy against recent price action in which the stock declined roughly 1% over the past week but has risen about 14% over the past year. InvestingPro analysis included with the filing indicates the stock appears overvalued relative to InvestingPro’s Fair Value metric, while noted analyst price targets cited in the material range from $7 to $14. The filing also references the availability of additional proprietary research and ProTips for subscribers seeking deeper analysis of ANIX.
FTAI Aviation Ltd. (NASDAQ: FTAI) - President David Moreno purchased ordinary shares totaling $498,143 on July 31, 2026, per the SEC filing. The transaction involved 2,475 ordinary shares acquired at $201.27 per share. Post-transaction, the filing records that Mr. Moreno directly holds 199,490 ordinary shares. In addition to his direct holdings, the filing lists indirect ownership of 4,354 ordinary shares and 8,000 Series D Preferred Shares held through a BVI corporation. The purchase occurred while the company’s shares were trading at about $206 and after a 12-month return of roughly 51%, according to the metrics included in the disclosure. InvestingPro commentary summarized in the filing indicates the company appears undervalued at current trading levels relative to InvestingPro’s Fair Value estimate.
V F Corp (NYSE: VFC) - President and Chief Executive Officer Darrell Bracken disclosed purchases totaling 32,894 shares of common stock on July 31, 2026. The shares were acquired at prices ranging from $14.90 to $15.08, producing a weighted average purchase price of $14.98 per share and a total consideration of $492,752. Following these purchases the filing reports Mr. Bracken’s direct holdings as 1,402,108.812 shares of V F Corp common stock. The transaction coincided with a period of pronounced volatility for the stock, which the filing shows was down 16% over the prior week and trading near $14.32. InvestingPro commentary accompanying the filing indicates the stock appears undervalued at current levels when compared to InvestingPro’s Fair Value estimate. The filing also notes that the company has maintained dividend payments for 56 consecutive years, and references the availability of detailed Pro Research Reports for investors seeking additional valuation context.
Top sells
Snowflake Inc. (NASDAQ: SNOW) - Christian Kleinerman, Executive Vice President of Product Management, reported sales of 29,986 shares of Snowflake common stock on July 31, 2026. The sales were executed at $300 per share and generated gross proceeds of $8,995,800. The transactions were carried out pursuant to a pre-existing Rule 10b5-1 trading plan that Mr. Kleinerman adopted on December 26, 2025. The Form 4 lists the breakdown of the sold shares as including 20,000 shares held directly by Mr. Kleinerman, 5,000 shares owned by the Kleinerman 2020 Dynasty LLC, and 4,986 shares held by the Kleinerman 2020 Nonexempt LLC. After these dispositions, Mr. Kleinerman’s direct holdings are reported at 375,379 shares, which include shares to be issued in connection with the vesting of restricted stock units. The filing also details substantial indirect beneficial ownership through multiple trusts and LLCs, including specified holdings by the Kleinerman 2020 Dynasty LLC and a series of Grantor Retained Annuity Trusts. The sale took place while Snowflake’s stock was trading near its 52-week high of $315.42 and at $307.53 at the time of the filing; InvestingPro commentary included in the materials characterizes the stock as overvalued relative to InvestingPro’s Fair Value.
Cactus, Inc. (NYSE: WHD) - Multiple insider dispositions were disclosed for July 30, 2026. President, Director and 10% owner Joel Bender sold 86,700 shares of Class A common stock through Bender Investment Company under a Rule 10b5-1 trading plan. The filing reports the sale price at $57.618 per share for aggregate proceeds of approximately $4,995,480. The filing states Mr. Bender disclaims beneficial ownership of the sold shares except to the extent of his pecuniary interest. Following the sale, the filing reports Mr. Bender’s direct holdings at 41,519 shares. On the same date Chairman and Chief Executive Officer Scott Bender also sold 86,700 shares of Class A common stock at the same per-share price and for the same aggregate amount, also through Bender Investment Company under a Rule 10b5-1 plan. The sales occurred while Cactus, Inc. shares were trading at $63.84 and near a 52-week high of $65.19; InvestingPro analysis cited in the filing indicates the stock appears slightly overvalued relative to InvestingPro’s Fair Value.
Rush Enterprises Inc. (NASDAQ: RUSHA) - W.M. "Rusty" Rush, who serves as CEO, President and Chairman of the Board, reported option exercises and subsequent sales in filings covering transactions on July 31 and August 3, 2026. On July 31, 2026, Mr. Rush exercised options to acquire 7,176 shares of Class A common stock at an exercise price of $15.06 per share, for an aggregate exercise cost of $108,088. Those shares were then sold at a weighted average sales price of $80.7598 per share, with individual sale prices for the block ranging from $81.00 to $81.3731. The filings indicate that in total, Mr. Rush disposed of shares generating roughly $6.38 million in proceeds across the reported transactions. At the time of the disclosure Rush Enterprises stock was trading at $80.96, near a 52-week high of $83.50, and the filing material notes the shares have appreciated more than 50% year-to-date. InvestingPro commentary included in the filing assesses the stock as currently overvalued against InvestingPro’s Fair Value estimate.
Each Form 4 filing provides exact transaction details - share counts, per-share pricing, total consideration, and changes in direct and indirect beneficial ownership - that allow investors and market participants to see how insiders are altering their stakes. Some sales were carried out under Rule 10b5-1 trading plans, while other disposals occurred following exercises of stock options. Several purchases were recorded as direct acquisitions, with some insiders increasing holdings in companies trading near recent highs or lows, and with InvestingPro commentary included in the filings offering valuation context indicating where those stocks sit relative to InvestingPro Fair Value estimates.
Monitoring insider activity can offer investors an additional data point when forming views on companies. Insider purchases may reflect confidence by executives and directors in their companies’ near-term prospects, while sales can be undertaken for a range of reasons including pre-arranged trading plans or liquidity events following option exercises. The filings reported here present a cross-section of both behaviors across banking, biotechnology, aviation leasing, apparel and cloud software-related companies.
All transaction details cited above are drawn from the respective Form 4 filings disclosed with the Securities and Exchange Commission on the dates noted. The filings contain transaction-specific facts including exact share counts, prices paid or received, the mechanisms of sale where applicable, and the post-transaction ownership positions reported by each insider.